Ultragenyx Pharmaceutical reported $6.43B in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Agios Pharmaceuticals AGIO:US $ 3.39B 211.72M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Aptinyx Inc APTX:US $ 192.93M 7.74M
Biocryst Pharmaceuticals BCRX:US $ 2.81B 1B
Biomarin Pharmaceutical BMRN:US $ 15.25B 1.45B
Bluebird Bio BLUE:US $ 2.16B 132.67M
Epizyme EPZM:US $ 847.42M 40.73M
Esperion Therapeutics ESPR:US $ 596.26M 193.51M
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Insmed INSM:US $ 3.22B 293.47M
IONIS PHARMACEUT IONS:US $ 5.62B 710.4M
Karyopharm Therapeutics KPTI:US $ 774.96M 14.69M
Kyowa Hakko Kirin 4151:JP 2127.6B 340.2B
Macrogenics MGNX:US $ 1.62B 176.65M
Mirati Therapeutics MRTX:US $ 8.31B 483.81M
Moderna Inc MRNA:US $ 94.35B 41.95B
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Ptc Therapeutics PTCT:US $ 2.98B 347.22M
Puma Biotechnology PBYI:US $ 370.52M 20.79M
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B
Vital Therapies VTL:US $ 266.65M 70.77M
Xoma XOMA:US $ 384.54M 74.98M